[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 481,788
  • Shares Outstanding, K 310,831
  • Annual Sales, $ 160,010 K
  • Annual Income, $ -546,380 K
  • EBIT $ -130 M
  • EBITDA $ 267 M
  • 60-Month Beta 2.31
  • Price/Sales 3.03
  • Price/Cash Flow 1.93
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 107.14% (+20.09%)
  • Historical Volatility 91.59%
  • IV Percentile 33%
  • IV Rank 19.54%
  • IV High 248.95% on 03/20/26
  • IV Low 72.70% on 07/14/26
  • Expected Move (DTE 21) 0.2210 (14.26%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 814
  • Volume Avg (30-Day) 1,166
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 68,947
  • Open Int (30-Day) 69,496
  • Expected Range 1.3290 to 1.7710

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.13
  • Number of Estimates 1
  • High Estimate $-0.13
  • Low Estimate $-0.13
  • Prior Year $-0.12
  • Growth Rate Est. (year over year) -8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0700 +44.86%
on 08/12/26
1.6100 -3.73%
on 08/26/26
+0.1900 (+13.97%)
since 07/27/26
3-Month
1.0700 +44.86%
on 08/12/26
1.8350 -15.53%
on 07/02/26
+0.2600 (+20.16%)
since 05/27/26
52-Week
1.0700 +44.86%
on 08/12/26
2.7300 -43.22%
on 01/23/26
+0.2200 (+16.54%)
since 08/27/25

Most Recent Stories

More News
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off

1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off

VSEC : 221.00 (-2.60%)
PACB : 1.5500 (-0.64%)
LEU : 194.78 (+3.81%)
5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call

5 Must-Read Analyst Questions From PacBio’s Q2 Earnings Call

PACB : 1.5500 (-0.64%)
PACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook

PACB Q2 Deep Dive: Leadership Transition and SPRQ-Nx Rollout Shape Outlook

PACB : 1.5500 (-0.64%)
PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

PacBio (NASDAQ:PACB) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

PACB : 1.5500 (-0.64%)
Pacific Biosciences: Q2 Earnings Snapshot

Pacific Biosciences: Q2 Earnings Snapshot

PACB : 1.5500 (-0.64%)
PacBio Appoints Mark Van Oene as President and Chief Executive Officer

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today...

PACB : 1.5500 (-0.64%)
PacBio Appoints Mark Van Oene as President and Chief Executive Officer

Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026...

PACB : 1.5500 (-0.64%)
PacBio Announces Second Quarter 2026 Financial Results

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026. ...

PACB : 1.5500 (-0.64%)
PacBio Announces Second Quarter 2026 Financial Results

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2026. Recent Business Highlights Total revenue of...

PACB : 1.5500 (-0.64%)
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry...

PACB : 1.5500 (-0.64%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 1.6867
2nd Resistance Point 1.6433
1st Resistance Point 1.5967
Last Price 1.5500
1st Support Level 1.5067
2nd Support Level 1.4633
3rd Support Level 1.4167

See More

52-Week High 2.7300
Fibonacci 61.8% 2.0959
Fibonacci 50% 1.9000
Fibonacci 38.2% 1.7041
Last Price 1.5500
52-Week Low 1.0700

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.